Your Article Summary
Risk Assessment for Opioid Misuse in Chronic Pain Treatment
Advances in Pain Management, 06/30/09
Weaver MF et al. - Many medications, including opioids, are effective for chronic pain, whether due to cancer or chronic non-malignant pain. However, opioids carry risks of misuse. Universal precautions in pain management involve the use of a medication agreement and ongoing monitoring such as urine drug testing. Screening for aberrant medication-taking behaviors (AMTBs) with specific screening tools can aid clinicians in stratifying patients according to degree of risk for initiating or maintaining opioids. This helps determine which patients need closer monitoring in addition to universal precautions. AMTBs can be addressed with good communication and recognition of the underlying cause, whether due to addiction, pseudoaddiction, or comorbid psychiatric disorders.
Related Articles
Review: limited evidence that psychological therapies are of benefit for adults with chronic pain
Evidence-Based Mental Health, 10/28/09
Relevance Score: 84%
The Development of an Integrated Treatment for Veterans with Comorbid Chronic Pain and Posttraumatic Stress Disorder
Pain Medicine, 10/14/09
Relevance Score: 84%
Psychiatry and chronic pain: Examining the interface and designing a structure for a patient-center approach to treatment
European Journal of Pain, 11/12/09
Relevance Score: 83%
Do illness perceptions predict pain-related disability and mood in chronic orofacial pain patients? A 6-month follow-up study
European Journal of Pain, 11/02/09
Relevance Score: 83%
Effect of Depression Treatment on Chronic Pain Outcomes
Psychosomatic Medicine, 10/30/09
Relevance Score: 83%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09
Blood Pressure, but Not Cerebrospinal Fluid Fentanyl Concentration, Predicts Duration of Labor Analgesia from Spinal Fentanyl
Anesthesiology, 12/11/09
Bupivacaine Inhibits Glutamatergic Transmission in Spinal Dorsal Horn Neurons
Anesthesiology, 12/11/09

See Latest Articles